Medicare Enrolled
Christopher Le
Rheumatology · Oldsmar, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Le from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Le?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Le
Christopher Le is a rheumatology specialist in Oldsmar, FL, with 9 years of NPI registration. Based on federal Medicare data, Le performed 20,680 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Le received a total of $18,890 from 46 pharmaceutical and/or device companies across 801 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Le is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 9 years of NPI registration
▲ Top 43% volume in FL
$18,890 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Osteopathic Physician | 16720 | Clear | March 31, 2028 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗20,680
Medicare services
Top 43% in FL for rheumatology
Not available
Unique patients (not deduplicated)
$9
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Tocilizumab injection (Actemra) | 11,882 | $5 | $14 |
| Romosozumab injection (Evenity) for osteoporosis | 6,930 | $8 | $22 |
| Denosumab injection (Prolia/Xgeva) | 1,080 | $18 | $44 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
151 | $95 | $270 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
118 | $8 | $20 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
91 | $54 | $189 |
| Complete ultrasound scan of joint An ultrasound exam that uses sound waves to create detailed images of a joint. This procedure allows for the visualization of the joint's internal structures. |
77 | $42 | $290 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
77 | $99 | $345 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
74 | $22 | $110 |
| Betamethasone steroid injection An injection containing a combination of betamethasone acetate and betamethasone sodium phosphate. |
69 | $5 | $12 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
49 | $131 | $364 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
41 | $112 | $411 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
22 | $48 | $207 |
| New patient office visit, complex (60-74 min) | 19 | $154 | $521 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
0.4% high complexity
97.8% medium
1.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$18,890
Total received (2018-2024)
Avg $3,148/year across 6 years
Top 25% in FL for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
46
Companies
801
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$5,459
2023
$5,616
2022
$3,521
2021
$3,565
2020
$717
2018
$12
Payments by company (2024)
Amgen Inc.
$974
Novartis Pharmaceuticals Corporation
$441
GlaxoSmithKline, LLC.
$424
UCB, Inc.
$414
Mallinckrodt Hospital Products Inc.
$387
PFIZER INC.
$371
ABBVIE INC.
$281
ANI Pharmaceuticals, Inc.
$253
Lilly USA, LLC
$251
Boehringer Ingelheim Pharmaceuticals, Inc.
$239
GENZYME CORPORATION
$230
E.R. Squibb & Sons, L.L.C.
$203
AstraZeneca Pharmaceuticals LP
$194
Janssen Biotech, Inc.
$180
Fresenius Kabi USA, LLC
$145
Aurinia Pharma U.S., Inc.
$115
Sandoz Inc.
$107
Kyowa Kirin, Inc.
$51
Alexion Pharmaceuticals, Inc.
$49
Genentech USA, Inc.
$45
United Therapeutics Corporation
$25
Organon Llc
$23
SOBI, INC
$22
Radius Health, Inc.
$21
Kiniksa Pharmaceuticals International, plc
$14
Top 3 companies account for 33.7% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$3,705
ABBVIE INC.
$1,553
GENZYME CORPORATION
$1,358
UCB, Inc.
$1,185
PFIZER INC.
$1,087
Janssen Biotech, Inc.
$954
GlaxoSmithKline, LLC.
$876
Mallinckrodt Hospital Products Inc.
$813
AbbVie Inc.
$782
E.R. Squibb & Sons, L.L.C.
$679
Boehringer Ingelheim Pharmaceuticals, Inc.
$679
Lilly USA, LLC
$636
Novartis Pharmaceuticals Corporation
$547
AstraZeneca Pharmaceuticals LP
$473
ANI Pharmaceuticals, Inc.
$457
Radius Health, Inc.
$426
Horizon Therapeutics plc
$416
Janssen Scientific Affairs, LLC
$334
Fresenius Kabi USA, LLC
$280
Aurinia Pharma U.S., Inc.
$264
SANOFI-AVENTIS U.S. LLC
$171
Organon LLC
$156
Sandoz Inc.
$148
Bayer HealthCare Pharmaceuticals Inc.
$132
Kyowa Kirin, Inc.
$99
Genentech USA, Inc.
$91
IDORSIA PHARMACEUTICALS US INC
$82
Alexion Pharmaceuticals, Inc.
$76
Kiniksa Pharmaceuticals, Ltd.
$65
Actelion Pharmaceuticals US, Inc.
$39
GRT US Holding, Inc.
$34
Allergan, Inc.
$30
Fidia Pharma USA Inc.
$28
Novo Nordisk Inc
$26
United Therapeutics Corporation
$25
Eisai Inc.
$24
Organon Llc
$23
SOBI, INC
$22
Amarin Pharma Inc.
$19
Boston Scientific Corporation
$19
Merck Sharp & Dohme Corporation
$14
Kiniksa Pharmaceuticals International, plc
$14
Ipsen Biopharmaceuticals, Inc
$12
Hikma Pharmaceuticals USA
$12
Eyevance Pharmaceuticals LLC
$12
Kowa Pharmaceuticals America, Inc.
$11
Top 3 companies account for 35.0% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AMJEVITA · Actemra · Arcalyst · BENLYSTA · BOTOX · Bimzelx · COSENTYX · CYLTEZO · Cimzia · Crysvita · Dayvigo · ELIQUIS · EVENITY · EVUSHELD · Enbrel · GENERAL - VASCULAR INTERVENTION · HADLIMA · HUMIRA · HYM/HYN · HYRIMOZ · IDACIO · ILARIS · KEVZARA · KINERET · KISUNLA · KRYSTEXXA · Kerendia · LUPKYNIS · Livalo · Mitigare · NUCALA · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · OMVOH · OPSUMIT · ORENCIA · Otezla · Ozempic · PNEUMOVAX 23 · PREVNAR 13 · PURIFIED CORTROPHIN GEL · Prolia · QULIPTA · QUVIVIQ · Qutenza · REMICADE · RENFLEXIS · RINVOQ · SAPHNELO · SIMPONI ARIA · SKYRIZI · STRENSIQ · TALTZ · TAVNEOS · TREMFYA · TYVASO · Tavneos · Tobradex ST · Tyenne · Tymlos · UBRELVY · UPTRAVI · Vascepa · XELJANZ · Xofluza
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Rheumatologists in nearby ZIP areas
54
County median income
$70,293
Nearest hospital to ZIP centroid (approximate)
MEASE COUNTRYSIDE HOSPITAL
2.7 mi
2.7 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Le is a mixed practice specialist, with moderate Medicare volume.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Le experienced with tocilizumab injection (actemra)?
Based on Medicare claims data, Le performed 11,882 tocilizumab injection (actemra) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Le receive payments from pharmaceutical companies?
Yes. Le received a total of $18,890 from 46 companies across 801 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Le's costs compare to other rheumatologists in Oldsmar?
Le's average Medicare payment per service is $9. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Le) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Rheumatologists in Oldsmar
Browse rheumatologists in Oldsmar ranked by procedure volume and transparency data.
Highest volume
Top Rheumatologists in FL
Rheumatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Rheumatologists in FL
Which FL rheumatologists receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
GENZYME CORPORATION Payments to Doctors
See all physicians who received payments from GENZYME CORPORATION.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology